Basic fibroblast growth factor (bFGF) has been shown to influence the survival, proliferation and differentiation of a variety of cell types in the nervous system. In this investigation we have examined the action of bFGF on: (i) the rate of proliferation; (ii) cell cycle parameters; (iii) the maintenance of cell division; (iv) the recruitment of quiescent cells; and (v) the degree of differentiation of cortical progenitor cells in cultures prepared from E16 rat embryos. The proliferation rate (labelling index) of cortical progenitor cells doubled in the presence of bFGF over 48 h. However, the lengths of the cell cycle phases were unchanged. Clones marked with a recombinant retrovirus on the first day in vitro (DIV) grew significantly larger in the presence of bFGF. Furthermore, many of the clones examined in control cultures had ceased to divide after a maximum of four cell cycles, whereas almost all clonally related cells were still dividing in the presence of bFGF 4 days later, i.e. for at least six cell cycles. Basic FGF also stimulated the division of quiescent progenitor cells, which otherwise would have differentiated or undergone cell death. The degree of neuronal and glial differentiation was studied after 5 DIV using MAP-2 and GFAP immunocytochemistry. In the presence of bFGF, the percentage of MAP-2-labelled cells was less than half that of control cultures, whereas the number of cells immunoreactive for nestin (a marker of progenitor cells) remained very high. Cells immunoreactive for GFAP were present in bFGF-treated cultures, yet were extremely rare in control conditions. These experiments show that bFGF, a potent mitogen for cortical progenitor cells, has no effects on the parameters of their cell cycle but extends their proliferative capability, promotes their survival and delays their differentiation into neurons.
The mammalian cerebral cortex is composed of neurons and glia generated over a relatively short period by the pseudostratified epithelium lining the telencephalic ventricles. Newly generated neurons migrate out to the cortical plate along a scaffold of radial glia, forming the layers of the cortex in an 'inside-out' manner, the deeper layers being formed first. In the mouse, the period of neurogenesis covers a mere 11 cell cycles between E11 and E16 (Takahashi et al., 1995a) . Each successive cycle takes ∼2 h longer than the previous, slowing from 8 to 20 h during this period. Other reports have suggested that a similar change takes place in the ventricular zone of the rat between E12 and E19 (Waechter and Jaensch, 1972) and in the monkey between E40 and E60 (Rakic, 1995) . Because neurons destined for different cortical layers are generated at different times (Sidman et al., 1959; Bayer and Altman, 1991) , the length of the cell cycle, together with the initial number of progenitor cells, is crucial in determining not only the size of each successive wave of postmitotic cells destined for the cortical plate but also the final composition of the cortex as a whole.
In contrast, cells in the subventricular zone that is responsible for gliogenesis from around birth in rodents (Boulder Committee, 1970) has been shown to maintain a constant cell cycle time in the mouse of ∼15 h during E14-E16 (Takahashi et al., 1995b) . The extrinsic and/or intrinsic determinants of the cell cycle in the proliferative neuroepithelium are not known at present, although there are indications that these factors may be expressed in a dorsolateral gradient (Reznikov and van der Kooy, 1995) and that particular regions of the neuroepithelium, such as that of the presumptive area 17 in the monkey, may have a much shorter cell cycle than their neighbours (Dehay et al., 1993) . Some studies have suggested that such variations in cycle time are intrinsic to the cells and may be retained when cortical progenitor cells are cultured in vitro. A population of cells isolated from embryonic rat cortices grew faster when prepared from E12 embryos than from E14 embryos , suggesting a possible difference in cycle time between these stages. In another study (Williams and Price, 1995) , cultured cells derived from E12 rat cortices grew more rapidly but were more sensitive to culture conditions than those prepared from later embryonic stages.
Apart from the lengthening of the cell cycle, proliferative cells of the ventricular zone become restricted in potential with time. A number of multipotential progenitor cells, able to give rise to both neurons and glia and with self-renewing properties (stem cells), were found in cultures of E12-E14 neuroepithelial cells Williams and Price, 1995) . At progressively later stages, progenitors with restricted potentials (including limited number of divisions and specified to produce either neurons or glia) predominate over the stem cell progenitors Williams and Price, 1995) . On the basis of the contemporaneity of the two events, it seems reasonable to correlate the lengthening of the cell cycle with the acquisition of specified fates. This step undoubtedly requires the activation of a number of fate-restricted transcription factors and genes, probably at the expense of the cell cycle machinery. Not surprisingly, the only phase of the cell cycle that is responsible for the lengthening is G1, when most of the transcription of the cellular genome takes place.
Extrinsic signals appear to be responsible for the transition from a population of multipotential, self-renewing stem cells to an overwhelming population of specified progenitors. These may include neurotransmitters (LoTurco et al., 1995) and growth factors. Recent reports have clarified the role in cortical neurogenesis played by two families of growth factors which are diffusely present in the embryonic telencephalon. Basic fibroblast growth factor (bFGF) represents one group of such factors. It is present in the embryonic cortex as early as E9.5 (Powell et al., 1991; Giordano et al., 1992) and throughout postnatal life (Gonzalez et al., 1990; Powell et al., 1991; Weise et al., 1993; Kuzis et al., 1995) . Basic FGF receptors are expressed during the development of the CNS and may precede the appearance of the growth factor itself (Wanaka et al., 1991; Kuzis et al., 1995) . In cultures, bFGF acts as a potent mitogen for many CNS populations (Cattaneo and McKay, 1990; Lillien and Cepko, 1992; Kilpatrick and Bartlett, 1993; DeHamer et al., 1994; Ray and Gage, 1994; Vicario-Abejón et al., 1995) . Besides its effects on a large population of neuroepithelial cells, bFGF specifically increases the numbers of glutamate-positive neurons in cultures derived from E12.5 rat embryos and the number of precursor cells expressing Otx2 (Robel et al., 1995) . Its role in cortical neurogenesis has been clarified recently by Ghosh and Greenberg (1995) , who showed that, while bFGF supports the proliferation of cortical progenitor cells, it does not preclude the action of members of another family of growth factors, the neurotrophins, which are specifically involved in triggering neuronal differentiation.
While the various actions of bFGF on proliferation, survival and differentiation of neuronal cells both in vitro and, to a lesser extent, in vivo have been documented (for a review see Baird, 1994) , its effects on phases of the cell cycle in such systems have not been fully investigated. In cultures of glial cells, bFGF stimulates mature cells to re-enter the cell cycle (astrocytes - Korr et al., 1992; oligodendrocytes -Freissnaud et al., 1993; Schwann cells -Peulve et al., 1994) and shortens the TC and TS to that of younger cells without changing the cell cycle of young cells themselves (Korr et al., 1992) . In this study we examined the action of bFGF on cortical progenitor cells in cultures prepared from E16 rat embryos with respect to their proliferation, cell cycle kinetics and differentiation. We found that although it increases the rate of proliferation of these cells, its effect is not mediated through the shortening of the cell cycle. Furthermore, bFGF delays the differentiation of neuronal, but not glial, progenitors by maintaining the cells in a proliferative mode and recruiting quiescent cells into the cell cycle.
Materials and Methods

Cell Cultures
Cultures were derived from E16 Sprague-Dawley rat telencephalons. Areas corresponding to the presumptive dorsal telencephalon were dissected out in Hanks' solution under a stereo microscope according to the atlas of the prenatal rat brain by Altman and Bayer (1995) . The meninges were carefully peeled away, and isolated tissue was dissociated enzymatically in Dulbecco's modified Eagle's medium (DMEM) (pH 7.0) with tr ypsin (0.1%) and DNase I (0.001%) for 30 min at 37°C. The treatment was continued with the addition of EDTA (0.5 mM) for 10 min at 37°C. Trypsin was inactivated by 10% fetal calf serum (FCS) in DMEM for 10 min and cells dissociated by delicate trituration with a sterile pipette tip. The resulting suspension was centrifuged at 1000 g for 3 min, the supernatant discarded and cells resuspended in serum-free DMEM:F12 (1:1). They were then plated at a density of 1.8 × 10 5 cells/ml on poly-L-lysine (10 µg/ml) and laminin (5 µg/ml) coated 13 mm coverslips in 24-well plates. Culture plates were kept in a humidified incubator (95% air/5% CO2) at 37°C and cells were allowed to attach to the coverslips for 30 min. Fresh medium containing 10% heat inactivated FCS, 100 µg/ml penicillin/streptomycin and 2 mM L-glutamine was then added, and on the following morning medium was replaced with N2-defined medium (Bottenstein and Sato, 1979) with or without the addition of 10 ng/ml bFGF (Promega).
Proliferation Rate
The rate of proliferation (labelling index; LI) in cultures, derived from four different experiments each taken from 12-16 rat embryos, was determined as the proportion of cells that incorporated bromodeoxyuridine (BrdU) after a 2 h exposure, a period long enough to label as many cells as possible in S phase without allowing them to enter mitosis. Four-, 24-and 48 h after the addition of the growth factor, 10 µM BrdU was added to the culture medium. Cells were washed, fixed with 4% paraformaldehyde, immunostained for BrdU and counterstained with propidium iodide (PI) (10 ng/ml). The percentage of cells immunoreactive for BrdU was counted using a ×40 objective lens in nine fields (62 500 µm 2 each) for each sample. We evaluated at least three samples for each time point and treatment, and significance was established using Student's t-test.
Estimation of Cell Cycle Parameters
The lengths of cell cycle phases were determined in four different experiments using the labelled mitoses method, with BrdU as a marker (Baserga, 1985) . Forty-eight hours after bFGF was added to the medium, a 15 min pulse of BrdU (10 -5 M) was given to control and bFGF-treated sister cultures. Sample coverslips were taken and fixed at hourly intervals up to 21 h after removal of BrdU, and processed for immunof luorescence (BrdU) and PI staining. For each time point, 2-3 coverslips were scanned using a ×63 oil immersion objective and at least 100 mitotic figures (metaphase/anaphase) were assessed for BrdU incorporation. The lengths of all phases of the cell cycle were calculated from plots of the percentage of BrdU-labelled mitoses.
Immunocytochemistry
Cultures were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 (PB), for 15 min. For estimates of LI and cell cycle parameters BrdU immunocytochemistry was performed first. Cultures were treated with 2 N HCl for 30 min, in order to expose BrdU-containing single strands of DNA, and neutralized with 0.1 M sodium borate buffer (pH 8.7). They were then incubated with an anti-BrdU monoclonal antibody (Sigma, 1:500) in a moist chamber at room temperature overnight. BrdU was visualized using a biotin-conjugated second layer, followed by streptavidin-f luorescein isothiocyanate (FITC) (1:250; Amersham). The cultures were counterstained for nuclei with 10 ng/ml PI and mounted in Citif luor. For combined β-galactosidase and BrdU immunocytochemistry, fixed cultures were first immunostained with a polyclonal anti-β-galactosidase antiserum (a gift of Dr J. Price) diluted 1:1000 and revealed with biotin-streptavidin-Texas Red, then treated with HCl as above prior to BrdU immunocytochemistry. BrdU-labelled nuclei were visualized using goat anti-mouse FITC (Sigma).
Monoclonal anti-MAP-2 (Boehringer), polyclonal anti-nestin (a gift of Dr R. McKay) and polyclonal anti-GFAP (DA KO) antibodies were used at a dilution of 1:1000 and visualized using biotin-streptavidin-diaminobenzidine (DAB) (Vector). Cultures were examined with conventional or confocal (Leica TCS-4D) microscopes equipped with appropriate epif luorescence filters.
Analysis of Cell Clones
To examine the effect of bFGF on the ability of cortical progenitor cells to continue dividing in vitro, the recombinant BAG-retrovirus (Price et al., 1987) carrying the reporter gene for β-galactosidase (β-gal) was used to mark a small number of progenitors. The progeny derived from these infected cells expressed the enzyme which was detected using immunocytochemistry.
Cultures derived from four experiments were infected with 10-20 colony forming units/ml of retrovirus for 16-20 h on the first day in vitro (DIV). This resulted in 4-8 clones of β-gal+ cells per coverslip. Three days later, BrdU was added to the medium for 12 h to label all cells that passed through S phase. Cultures were immediately fixed, and dual immunofluorescence staining was used to identify clonally related cells (β-gal+) and those that had also incorporated BrdU. A clone was defined as a cluster of β-gal+ cells, each cell being no further than 50 µm from its neighbours. There were 152 such clones examined in control conditions, and 108 in bFGF-treated cultures.
Neuronal and Glial Differentiation
To examine the degree of differentiation of cultured cells when grown in the presence or absence of bFGF, cultures from 4 different litters were fixed 4 h after plating or after 5 DIV and immunostained for nestin (a marker for undifferentiated stem cells), MAP-2 (a neuronal marker) or GFAP (an astrocyte marker). For each treatment, the proportion of immunopositive cells was determined from at least 1,200 cells per experiment in 6 or more randomly selected fields under a ×40 objective lens.
Quiescent Cells
To examine whether there was a population of cells that only entered the mitotic cycle after some time and whether this was stimulated by the presence of bFGF, an analysis using dual BrdU and [
3 H]thymidine labelling was carried out. Cultures from two litters were grown in the continuous presence of BrdU (10 µM) for 34 h. Following extensive washing, the medium was replaced for a further 14 h by fresh BrdU-free medium containing 0.5 µmol/ml [ 3 H]thymidine (60-80 Ci/mmol, Amersham). Cultures were then fixed and processed for BrdU immunocytochemistr y using peroxidase and diaminobenzidene as substrates. The coverslips were air-dried and dipped in diluted G5 emulsion (Ilford) at 35°C. After gelling the emulsion on ice and gentle drying, they were stored at 4°C for 4 weeks before development in D-19 for 4 min at 20°C. Toluidine blue was used as a counterstain. 
Dying Cells
Cells with condensed chromatin, a sign of apoptotic cell death (Wyllie et al., 1980) , were easily visualized after staining with propidium iodide, toluidine blue or terminal transferase nick end-labelling (TUNEL; Gavrieli et al., 1992) . For TUNEL histochemistry, cultures were fixed with 4% paraformaldehyde and incubated for 5 min in terminal deoxytransferase (TDT) buffer (200 mM sodium cacodylate, 25 mM Tris/HCl, 0.25 mg/ml BSA, pH 6.6) and then in the following mixture for 1 h at 37°C: 74 µl double-distilled water, 20 µl TDT buffer (5×), 5 µl cobalt chloride (25 mM), 0.5 µl digoxigenin-11-dUTP (Boehringer) and 0.2 µl TDT (Boehringer). A fter incubation, cultures were reacted with digoxigenin-FITC antiserum (Boehringer) at a dilution 1:500. Double staining with PI and TUNEL, PI and toluidine blue or TUNEL and toluidine blue showed that all these techniques stained the same population of dying cells (data not shown). 
Results
General Appearance of Cultures
Cultures used in this study were plated at a density of 1.8 × 10 5 cells/ml, and in defined medium remained viable for at least 6-7 days, but at lower densities their survival was limited. Four hours after plating, cells typically had a varied morphology, showing a few short processes (see Fig. 4 ). Four days later they had a different appearance depending upon the treatment; they formed a meshwork of aggregates of several hundred cell bodies interconnected by their processes. Typically, these cells had a multipolar morphology with long varicose processes extending 100 µm or more from the cell body. In the presence of 10 ng/ml bFGF, their density increased rapidly to form large densely packed clusters and could be maintained in culture for several weeks. Rounded cells with heavily condensed chromatin, suggestive of dying cells, were often found in control cultures but were less common in those treated with bFGF. A number of large, f lat cells were also present in these cultures; they were few in number and at 7 DIV or later showed immunoreactivity to GFAP (data not shown), suggesting that they may be of the astrocyte lineage.
Proliferation Rate
Changes in the proliferation rate of cells in culture were estimated by determining the percentage of cells able to incorporate BrdU into their nuclei during a 2 h pulse. Initially, 4 h after the addition of bFGF to the medium, there was no difference between the two experimental groups (21 ± 1.5% in defined medium and 18.8 ± 1.2% in the presence of bFGF). After 24 h, labelling in control cultures had fallen to 12 ± 0.8% and was further reduced after 48 h to 8.7 ± 0.7%. In the presence of bFGF, however, the percentage of BrdU-labelled nuclei at 24 h was maintained at 20.9 ± 2.2% and rose appreciably to 35.4 ± 2.5% (P < 0.005 compared with controls) after 48 h.
Cell Cycle
To estimate the duration of cell cycle phases, cultures were given a 15 min pulse of BrdU and the percentage of labelled mitotic figures was determined at intervals up to 21 h later (Fig. 1) . The duration of each phase was measured between the 50% labelling points (Baserga, 1985) . TG2+M, TS and TC were determined directly from the curves, TG1 = TC -(TS + TG2+M). For the representative cultures illustrated in Figure 2a , the cell cycle length was estimated to be 12.5 h (TG2+M = 2.5 h, TS = 7.5 h and TG1 = 2.5 h).
We found that it was important to compare control and bFGF-treated cultures prepared from the same pool of cells, as small variations in cell cycle times occurred between preparations (e.g. a TC of 14 h compared with 12.5 h mentioned above). Most often the cycle time was just over 12 h, but it was never shorter. However, for cultures prepared in parallel there was no difference in the lengths of cell cycle phases between the two growth conditions, suggesting that variations in medium composition or culture procedures affected the control and experimental cultures to the same extent. For each treatment, using data from four separate experiments, linear regression lines were constructed for the two ascending slopes of the labelled mitoses curves (Fig. 2b) . The slopes of the regression lines derived from control cultures were less steep than those from bFGF-treated cultures, but both sets crossed the 50% labelling points within a few minutes of each other, giving a TC of 12.5 h for both conditions.
One of the criticisms of the labelled mitosis method may be that TC is measured for the fastest cycling cells and TS is for the slowest cells. But with the short pulse of BrdU given here (15 min), any errors that could arise from variations in clearance times (e.g. with [ 3 H]thymidine in vivo) are eliminated. The steep and symmetrical initial slopes of the mitoses curves shown in Figure 2 indicate that the cell populations are fairly homogeneous with respect to the timing of the phases of their cell cycles; the slower second ascending slope is due partly to asynchrony of cycle times and partly to detectability of the diluted label in daughter cells of the first division. A mixed population including significant numbers of cells with very long cycle times would have resulted in f latter curves with less pronounced peaks and troughs.
Analysis of Clones
In cultures that had been infected with the BAG-retrovirus and allowed to grow for a further 3 days, there was a distinct difference in the β-gal-labelled clones between those grown with or without bFGF (Fig. 1) . Both the average number of cells per clone and the maximum clonal size were larger when grown in the presence of bFGF. In control cultures, the majority of clones had eight cells or fewer (average 5.5, maximum 16; 152 clones counted), whereas treated cultures had clones containing up to 45 cells, with an average of 16.7 (108 clones counted). In Figure  3 these results are shown graphically in terms of the maximum number of cells produced by a symmetrical pattern of cell divisions. If this mode of division was operating, then in control conditions clones were the result of no more than four divisions of a single progenitor. Similarly, in the presence of bFGF the majority of clones had cells derived from at least four divisions and some were derived from six cell divisions. This latter value is consistent with the 12.5 h cycle time estimated above -allowing for one mitosis to pass for integration of the virus into one daughter cell (Hajihosseini et al., 1993) ; at the end of 3 days (or six full cycles) the maximum possible clonal size would be 64 cells. Only four clones out of 108 examined were in the 33-64 cell range (i.e. resulting from the sixth division) and there were no clones larger than this, showing that the cycle time could not be significantly faster than our estimate. There are a number of explanations for why so few clones had attained this size: the unknown and probably variable length of time for incorporation and expression of the retrovirus, the asynchronous timing of divisions within the cell population, cells leaving the cycle and becoming postmitotic, the unknown number of cell cycles that had been completed and the extent of cell death.
In an attempt to understand the difference in clonal sizes between the two treatments, we analysed the number of cells in each clone that were still proliferating during the final 12 h of this experiment by their ability to incorporate BrdU. Of clones examined in control conditions, 75% contained cells that had stopped dividing before BrdU was added, compared with only 14% of the clones examined in the presence of bFGF. In more detail, nearly half (48%) of the cells in clones of control cultures were immunonegative for BrdU, whereas only 3% of the cells within clones grown with bFGF had stopped dividing.
MAP-2, GFAP and Nestin Immunoreactivity
Four hours after plating, 17% of the cultured cells were labelled for MAP-2 (Table 1, Fig. 4 ) and 93% showed nestin immunoreactivity. No GFAP-immunoreactive cells were found at this stage. A fter 5 DIV in defined medium, the proportion of M AP-2-labelled cells had risen to 37%, whereas those immunoreactive for nestin had fallen to 13%. There were only a few cells immunoreactive for GFAP in defined medium (<1%). However, when grown in the presence of bFGF for 5 DIV, the percentage of MAP-2-labelled cells was reduced to 5%, GFAPimmunoreactive astrocytes had increased to 27% and the nestin-immunoreactive population remained very large at 94%. No coexistence between MAP-2 and nestin immunoreactivity was found in any of the conditions studied, except at 4 h after plating (not shown).
Quiescent Cells
A double-labelling protocol of the S phase markers BrdU and [ 3 H]thymidine was used to discriminate between cells that were cycling during the initial stages of the experiment from those that only entered the cell cycle during the last few hours. Examination of the autoradiograms ref lected the results obtained above, in that (i) a higher percentage of the population were still cycling at the end of the experiment in the presence of bFGF compared with control conditions; and (ii) many cells in defined medium had become postmitotic both before the addition of BrdU to the medium (46%; Table 2 ) and before the addition of [ 3 H]thymidine (80%). Furthermore, in the presence of bFGF there was a small population of cells (4%) that had incorporated [ 3 H]thymidine during the final hours but were BrdU-immunonegative (Fig. 5B) . As BrdU was available in the medium for 34 h before replacement by the radioactive marker, these cells must have entered S phase for the first time after at least the length of the BrdU availability plus the length of the S phase. Such cells were not found in the control cultures (Fig. 5A) .
Dying Cells
A number of cells with condensed chromatin, indicative of apoptotic cell death, were visualized in cultures stained with PI or toluidine blue (Fig. 5) . This was confirmed in cultures processed with the TUNEL method. There were twice as many dying cells in cultures grown in defined medium than in the presence of bFGF. In the previous experiment we noticed that cells with condensed chromatin were often labelled with [ 3 H]thymidine or BrdU (Fig. 5C ). The presence of unlabelled dying cells confirmed that the uptake of these thymidine analogues was not due to non-specific labelling as a result of the dying process (Table 2) . While the data in Table 2 show that 29% of the dying cells in defined medium had incorporated neither of the S phase markers (column A, line 6), and so cannot have been cycling during the course of this experiment, the remaining 71% must have died soon after attempting to divide (columns B + C + D, line 6). In the presence of bFGF, the situation was similar (compare column A with columns B + C + D, line 8: 24 and 76% respectively). There was little difference in the relative proportion of each population of dying cells between the two treatments. However, in defined medium all cells in the last group, which had only incorporated [ 3 H]thymidine in the last 14 h, had died (column D, lines 1 and 5), whereas in bFGF the majority of them survived (column D, lines 3 and 7: 39 out of a total of 55 cells).
Discussion
In the present study we analysed the mitogenic effects of bFGF on E16 rat cortical progenitor cells with respect to cell cycle parameters, extension of the proliferative period and recruitment of quiescent cells into division. We found that, although bFGF is effective in keeping cortical progenitor cells in a proliferative mode and in stimulating quiescent cells to divide, it has no effect on the kinetics of cell division. In addition, our study shows that neuronal differentiation is delayed in the presence of bFGF, thus corroborating the hypothesis that proliferation and neuronal differentiation are sequential events in the development of cortical cell lineages. These results suggest that the decision to continue proliferation may be mediated by growth factors and be completely independent from the lengthening of the cell cycle that takes place in the mammalian cerebral cortex during development.
Growth Factors and the Choice between Cell Division and Differentiation
Several lines of evidence point to the importance of extrinsic factors in promoting either cell cycle arrest or commitment to cell division. Cell-cell contact has been shown to be necessary for cell proliferation, probably through membrane-associated molecules . In contrast, neurotransmitters such as GABA and glutamate, either directly applied in vitro (LoTurco et al., 1995) or released from pioneer axons growing into the ventricular zone (Gong and Shipley, 1995) , stop cell division and promote the production of postmitotic neurons. Growth factors have complex effects on neural cells that differ greatly, probably in relation to the state of differentiation of their cellular targets. Neurotrophins have little stimulatory effect on the proliferation of cortical neuroepithelial cells (reviewed in Temple and Quian, 1995) , but promote their survival and differentiation into various neuronal phenotypes (Ghosh and Greenberg, 1995; Vicario-Abejón et al., 1995; Pappas and Parnavelas, 1997) . Polypeptide growth factors, including epidermal growth factor and FGFs, are more effective as mitogens. D cyclins, which regulate cell cycle progression in G1, are likely to be among the targets of their activity. Basic FGF needs to be present in early G1 to exert its effects on proliferation (DeHamer et al., 1994) . In many in vitro systems, withdrawal of growth factors leads to rapid degradation of D cyclins and a failure to enter S phase (Matsushime et al., 1991) . Accordingly, down-regulation of the FGF receptor is required for terminal differentiation of myogenic cells (Itoh et al., 1996) .
All this evidence suggests that the decision to exit the cell cycle may take place at any stage of the development of cortical cell lineages, as indicated by the production of postmitotic neurons from the early stages of corticogenesis (Takahashi et al., 1994) , and is unrelated to the lengthening of the cell cycle time, which is a population event. It is known that during embryonic Table 2 Quiescent and dying cells in E16 telencephalic cultures development the length of the cell cycle progressively increases, initially through the insertion of the two gap phases (G1 and G2), then through the lengthening of G1 (see Murray and Hunt, 1993) . This event is probably related to the increasing amount of genetic material that needs to be transcribed during each successive cell cycle. It is tempting to speculate that an increase in transcription corresponds to the acquisition of specialization in these progenitor cells. In addition, cells may 'sense' the number of mitotic divisions they have undergone and 'know' that they are maturing. It is possible that this maturation leads to an end of their proliferative ability, and may represent another mechanism for the production of postmitotic cells which takes place for the remaining population as a whole, as opposed to the individual choice of isolated cells at early stages. It may correspond to the maximum number of cell divisions 'allowed' to a given cell type before differentiation: see, for example, the production of oligodendrocytes after a predetermined number (8) of cell divisions (Barres et al., 1994 ; for a review see ffrench-Constant, 1994).
In Vitro Models to Study the Cell Cycle Parameters of Cortical Progenitor Cells
Primary cultures of cortical neuroepithelial cells are widely used to investigate the mechanisms of neuronal and glial differentiation (Temple, 1989; Cattaneo and McKay, 1990; Davis and Temple, 1994; Robel et al., 1995; Vaccarino et al., 1995; Williams and Price, 1995) . However, this in vitro model has been used less frequently to study the intrinsic and extrinsic determinants of the cell cycle, despite the strict relation between cell cycle and cell differentiation (for a review see Ross, 1996) . One of the problems encountered by investigators is that neuroepithelial cells show short survival times when cultured in defined medium; most of the cells that survive halt proliferation to undergo neuronal differentiation (Ghosh and Greenberg, ]thymidine were found (arrows); a double-labelled mitosis can also be seen here (asterisk). Cells with apoptotic characteristics were found under both conditions but were more common in the controls. An apoptotic cell labelled with [ 1995) and few cells continue to proliferate, thus making these cultures not so suitable to study cell cycle parameters. A few investigators have used dissociated cultures (DeHamer et al., 1994; Dehay et al., 1995) or slice cultures (Miyama et al., 1995) to investigate cell cycle parameters in neural cells, but the reports are still preliminary. In the presence of bFGF, however, most neuroepithelial cells continue to proliferate. We chose this culture model to verify whether growth factors, and in particular bFGF, could be responsible for the short cycle time of early cortical progenitor cells. Basic FGF is present during early embryogenesis in the telencephalic ventricular zone and exerts potent mitogenic effects on a range of neural cell types (for a review see Baird, 1994) . It also acts as a neural inducer (Lamb and Harland, 1995) , and shortening of the cell cycle time has been shown to occur during the formation of the primitive streak (MacAuley et al., 1993) .
We found that E16 neuroepithelial cells, which have a cell cycle of 15 h in vivo (Waechter and Jaensch, 1972; Reznikov and van der Kooy, 1995) , shorten their cycle to 12.5 h after 4 days in culture. This was in contrast with what we expected, given the progressive lengthening of the cell cycle time that takes place in vivo (Takahashi et al., 1995b) . By E19, the corresponding age in vivo for the cultures when we assay their cycle parameters, the cell cycle should be ∼18 h. We have yet to investigate whether this 12.5 h represents a default cell cycle length for proliferating neuroepithelial cells to which the cells revert as soon as they escape the control of extrinsic factors present in vivo. A further suggestion is that whatever factor(s) is responsible for a cell cycle length of 15 h in vivo, that factor(s) is lacking or has no effect in our cultures. In addition, we found that in these conditions bFGF was unable to shorten the cell cycle any further.
How Does bFGF Increase the Number of Neuroepithelial Cells?
Our data indicate that the proliferative effects of bFGF on cortical progenitor cells in culture do not include a shortening of the cell cycle time. We found that bFGF increased the population of neuroepithelial cells through at least two different mechanisms. Firstly, bFGF increased the number of mitotic divisions through which proliferating cortical neuroepithelial cells may pass in culture. Similar effects of bFGF were described by DeHamer et al. (1994) in cultures of olfactory neurons, where it was shown that bFGF exerts its effects on a committed population of cycling precursor cells (the immediate neuronal precursors). These cells normally undergo only one round of cell division in culture, but in the presence of bFGF most of these cells divide twice. In addition, DeHamer and colleagues (1994) showed that bFGF supports the survival and proliferation of stem cells. Similar effects of bFGF were found in a study on dopamine cell precursors from E12 rat ventral mesencephalon (Bouvier and Mytilineou, 1995) , which showed that this growth factor enabled these cells to continue dividing for at least 8 DIV instead of just one. Differentiation of these cells was also considerably delayed by bFGF.
The proportion of nestin-immunoreactive cells, the progenitors to both neuronal and glial cortical cells (Lendahl et al., 1990) , remained high in the presence of bFGF. In contrast, the proportion of MAP-2-positive cells, which are considered as terminally differentiated postmitotic neurons, decreased. Unfortunately, the lack of markers does not allow us to know if an intermediate precursor to cortical neurons, committed but still cycling, exists in the developing cortex similar to the olfactory epithelium, or whether this precursor may be responsive to bFGF. However, since the two main categories of cells in cultures of E16 cortex (nestin-and MAP-2-immunoreactive) seem to be mutually exclusive classes of cells or stages of maturation, it is likely that any committed cycling precursor to cortical neurons may be part of the nestin-positive population, which is the only one that is cycling and, therefore, is a target for the proliferative effects of bFGF.
The second mechanism through which bFGF increases the number of proliferating neuroepithelial cells is by stimulating quiescent cells to divide and by supporting them in successfully completing this task. Although the number of these cells appears to be small, judging from the present study and previous reports (Morshead et al., 1994) , they may represent a source of a large number of proliferating and differentiating cells due to clonal expansion (Reynolds and Weiss, 1996) . These cells may therefore represent a population of slowly cycling stem cells which are responsive to bFGF (Gritti et al., 1996) . We do not know whether the cells that die in defined medium while attempting to divide are quiescent progenitors or fully postmitotic cells. However, our results suggest that it is the same population of quiescent cells that successfully complete division in the presence of bFGF, while in the absence of the growth factor undergo cell death.
